Clinical trial
Evaluation of the Efficacy of Isotretinoin Versus Placebo in Terms of Response Rate Among Patients Presenting Papular-pustular Rosacea Resistant to Standard Therapy
NCT00882531 is registered in ClinicalTrials.gov with Laboratoires Bailleul-Biorga as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Isotretinoin Versus Placebo in Terms of Response Rate Among Patients Presenting Papular-pustular Rosacea Resistant to Standard Therapy
- Lead sponsor
- Laboratoires Bailleul-Biorga
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- September 30, 2009
- Enrollment
- 156 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
papular-pustular rosacea